Today’s blog is from Ahmed Alharthi, who in undertaking a PhD at the University of Glasgow. Ahmed talks about the PhD journey.

I am a licenced clinical pharmacist by background, who works with Dr Terry Quinn, a consultant physician and geriatrician in the NHS and a reader in Geriatric Medicine department at the University of Glasgow. I am a second year PhD student, employed and sponsored by Umm Al Qura University in Saudi Arabia.

I completed my MSc in Clinical Pharmacology at the University of Glasgow, and then started to pursue my PhD in Cardiovascular Medicine. My PhD title is “Repurposing cardiovascular medicines for vascular dementia – a data driven clinical study”. My PhD work so far has focussed on dementia and associations with a group of medications called Anticholinergic drugs. I wish to understand the potential relationship between these commonly used medications and the incidence of dementia in older adults, because if there is a causal relationship this could suggest a potential modifiable risk factor.

In my work so far, I have conducted systemic reviews focused on evidence synthesis and had the opportunity to collaborate with the Cochrane Dementia Group, resulting in published paper. I am currently working on a dataset from a completed cohort the APPLE study. This offers me participant-level data that contain high-quality information on medications prescribed and consumed, with detailed information on changes in medication over time. This level of detail is often missing in studies that contain information on prescribed medications, but to truly understand the relationship between medications and dementia this granularity of medication data is required.

Given my professional background, I was eager for my PhD to include content related to clinical pharmacy practice. Among the ideas I have discussed with my supervisors are a real-world analysis of anticholinergic prescribing in Greater Glasgow and Clyde secondary care and a qualitative piece contrasting prescribers’ opinions on anticholinergic prescribing and the use of scales to identify anticholinergic risk.

I was motivated towards pursuing a PhD with a cognition and medications focus, as I was aware of the crucial role of clinical pharmacy to enhance medications use and possibly to improve cognitive impairment by adopting novel treatment approaches.

I am especially excited around the next step of my research, working with Dr Donald Lyall, my second supervisor. I will move from a relatively large dataset (APPLE Study) to a truly bigdata project, assessing for associations of cardiovascular medications and dementia in the UK Biobank, one of the largest biomedical databases in the world.

I am keen to engage with the Scottish dementia research community and look forward to meeting other researchers.

Read more SDRC Blogs

SDRC Annual Report 2022/23: Diagnosis

This blog is an extract from the SDRC Annual Report 2022/23, dedicates a section to the progress and ongoing work of each of the SDRC research themes.  This blog is from the Diagnosis theme, written by theme leads Dr Terry Quinn and Dr Jennifer Macfarlane. Summary of...

I Got Involved and then it was Radio Silence

In today's Research Involvement blog, we are featuring Marion Ritchie, member of the National Dementia Carers Action Network (NDCAN) who has been involved in research for many years. Marion is just one of many people we have been speaking to their experiences of...

Guest Blog: Young Dementia Network

Guest Blog: Young Dementia Network   The Young Dementia Network is an online influencing community working collaboratively to improve lives of people living with young onset dementia and their families now and create positive change for the future. Launched in...

Early Career Researchers: Laura Aitken

Throughout August, the SDRC are celebrating our next generation of researchers by publishing a series of blogs to PhD Students/ Early Career Researchers.  For the first week, we are featuring those that were in the SDRC Impact Report 2019. Our next blog is from Laura...

COVID Impact on Research: Principal Investigator Blog- Dr Terry Quinn

Following on from the success of our SDRC Early Career Researcher guest blogs, we wanted to represent our more established researchers as well. We are delighted to share a blog from Dr Terry Quinn, Clinical Senior Lecturer from the University of Glasgow and SDRC...

Early Career Researchers: Kieren Egan

We are delighted to share this guest blog from Kieren Egan, a Research Associate from the University of Strathclyde. Read below about Kieren's own PhD experience and life beyond in various research posts around the world. Kieren's blog is part of an entire series of...

SDRC Annual Report 2021/22: Informatics & Technology

The following is an excerpt of SDRC Annual Report 2021/22 which provides on overview of the research in the field of brain health Informatics & Technology, written by theme lead and SDRC Executive Committee member Dr Mario Parra Rodriguez. The SDRC is witnessing a...

Early Career Researchers: Stina Saunders

Throughout August, the SDRC are publishing a series of blogs from PhD Students/ Early Career Researchers in dementia and brain health.   For the first week, we are featuring those that were in the SDRC Impact Report 2019.  Read about Stina Saunders' research as a PhD...

SDRC Conference: A view from the National Dementia Carers Action Network

The SDRC Annual Conference, held on 15th April 2019, brought together attendees from all over Scotland to hear about the latest developments in dementia research. In attendance at the conference as well were representatives from groups that work very closely with the...

COVID Impact on ECRs: Miriam Scarpa

In the coming days, the SDRC are publishing a series of blogs featuring Early Career Researchers who are sharing how COVID has impacted their research and career prospects. The first blogs in this series also featured in our COVID Research Impact Report which we...